Article
Expert Panel Recommends Nod to Serum Institute for Phase 2/3 Covovax Trials on Kids
Rating:
0.0
Views:
73
Likes:
1
Library:
1
An expert panel of India's Central Drug Authority on Tuesday recommended granting permission to Serum Institute of India (SII) for conducting phase 2/3 trials of Covovax on children aged 2 to 17 years with certain conditions, official sources said.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value